FDA panel reviews 1st new Alzheimer’s drug in 2 decades


FDA panel reviews 1st new Alzheimer’s drug in 2 decades






A panel of outside experts meets Friday to advise the Food and Drug Administration on aducanumab, a drug from Cambridge, Massachusetts-based Biogen Inc. and Japan’s Eisai Co. FDA doesn’t always follow the panel’s advice but usually does and has until March to decide.



via FOX BUSINESS NEWS https://ift.tt/38f7cTK Markets

About Real business info


There are so many different possibilities to start an online business with real business info, We will guide you to choose the best business for you and earn as much money as possible

don't forget to subscribe to get us latest business news

Post a Comment

0 Comments